Last news
Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

BOSTON, Feb. 14, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa), a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders, today announced the successful completion of its...

Tuya to Report Fourth Quarter 2024 Financial Results on February 26, 2025 Eastern Time

Tuya to Report Fourth Quarter 2024 Financial Results on February 26, 2025 Eastern Time

SANTA CLARA, Calif., Feb. 14, 2025 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading cloud platform service provider, today announced that it will report its fourth quarter 2024 unaudited financial...

Thousand-year-old temple fair held in Central China's Henan

Thousand-year-old temple fair held in Central China's Henan

XUN COUNTY, China, Feb. 14, 2025 /PRNewswire/ -- On February 6, 2025, the ninth day of the first lunar month, the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibrant display of traditional...

Snail Games Celebrates Pivotal Milestones and New Content for the ARK Franchise

Snail Games Celebrates Pivotal Milestones and New Content for the ARK Franchise

CULVER CITY, Calif., Feb. 14, 2025 /PRNewswire/ -- Snail Games (Nasdaq: SNAL), a premier global developer and publisher of interactive digital entertainment, celebrates new milestones that are reshaping the ARK universe. The franchise has expanded...

Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA

Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA

SHENZHEN, China, Feb. 14, 2025 /PRNewswire/ -- Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05, Human Interferon α1b Inhalation Solution, a self-developed product by...

LONGi maintains AAA ranking in Q4 2024 PV ModuleTech Bankability Ratings

LONGi maintains AAA ranking in Q4 2024 PV ModuleTech Bankability Ratings

XI'AN, China, Feb. 14, 2025 /PRNewswire/ -- LONGi has announced the retention of its AAA rating in PV-Tech's Q4 2024 PV ModuleTech bankability ratings, marking the company's 20th consecutive quarter at this top tier and underscoring its long-term...

BingX Labs Invests $100,000 in Fireverse to Fuel AI Music Innovation in Web3 Initiatives

BingX Labs Invests $100,000 in Fireverse to Fuel AI Music Innovation in Web3 Initiatives

PANAMA CITY, Feb. 14, 2025 /PRNewswire/ -- BingX Labs, the innovation arm of cryptocurrency exchange BingX, announced a strategic $100,000 investment in Fireverse, a trailblazing AI-driven and blockchain-powered music creation platform. This...

China Telecom's Asia Direct Cable (ADC) Capacity Enters Service Ahead of Schedule, Bolstering Regional Economic Development

China Telecom's Asia Direct Cable (ADC) Capacity Enters Service Ahead of Schedule, Bolstering Regional Economic Development

HONG KONG, Feb. 14, 2025 /PRNewswire/ -- On February 14, 2025, China Telecom officially announced that the capacity of the Asia Direct Cable (ADC), an international submarine cable initiative led by China Telecom, has been officially in service...

menu
menu